openPR Logo
Press release

Pharmaceutical Pellets Market Report 2026 Market Outlook Supported By A Forecast 11.7% CAGR

10-27-2026 07:36 AM CET | Health & Medicine

Press release from: The Business Research Company

Pharmaceutical Pellets Market

Pharmaceutical Pellets Market

The pharmaceutical pellets market has been experiencing rapid expansion due to advances in drug delivery technologies and rising healthcare demands. This growing sector is expected to continue its upward trajectory as innovations and increasing patient needs drive further adoption of pellet-based formulations. Let's explore the current market size, key factors fueling growth, prominent players, and emerging trends shaping the pharmaceutical pellets industry.

Pharmaceutical Pellets Market Size and Growth Outlook
The pharmaceutical pellets market has seen significant growth in recent years, with its size anticipated to increase from $2.01 billion in 2025 to $2.24 billion in 2026, marking a compound annual growth rate (CAGR) of 11.4%. This expansion during the historical period is largely due to the rising occurrence of chronic diseases, an increased demand for modified release dosage forms, technological progress in extrusion and fluid bed methods, growing pharmaceutical manufacturing capabilities, and heightened emphasis on patient adherence to medication.

Download a free sample of the pharmaceutical pellets market report:
https://thebusinessresearchcompany.com/sample_request?id=21816180&type=smp&name=Pharmaceutical%20Pellets%20Market%20Report%202026&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Oct_PR

Looking ahead, the pharmaceutical pellets market is poised for robust development, expected to reach $3.48 billion by 2030 with a CAGR of 11.7%. The forecasted growth is driven by advancements in precision drug delivery, expanded use of pellets in combination therapies, growing interest in nutraceuticals and functional ingredients, innovations in solvent-free and melt-based manufacturing techniques, and the rise of contract manufacturing organizations. Key trends anticipated to influence this period include greater adoption of multi-particulate drug delivery systems, increased demand for controlled and sustained-release medications, wider use of pellets in capsules and sachets, growth in pellet applications within nutraceuticals, and improvements in coating and layering technologies.

Key Factors Boosting Pharmaceutical Pellets Market Expansion
One crucial factor fueling the pharmaceutical pellets market is the growing prevalence of chronic illnesses worldwide, which necessitates more effective and patient-friendly medication delivery methods. This has led to heightened interest in modified release formulations that offer better control over drug dosage and timing.

View the full pharmaceutical pellets market report:
https://www.thebusinessresearchcompany.com/report/pharmaceutical-pellets-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Oct_PR

Another important driver is the progress in manufacturing technologies such as extrusion and fluid bed granulation. These advancements have improved the efficiency and scalability of pellet production, enabling pharmaceutical companies to meet increasing demand while maintaining high quality and consistency.

Top Companies Leading the Pharmaceutical Pellets Market
The pharmaceutical pellets industry features a competitive landscape with several major corporations playing a significant role. Key market participants include Abbott Laboratories, Takeda, Boehringer Ingelheim, Teva Pharmaceutical Industries Ltd., Eisai Co. Ltd., Colorcon Inc., Nordic Sugar AB, Pfizer, Merck & Co., Manus Aktteva Biopharma LLP, Thexa Pharma (P) Limited, Avanscure Lifesciences Private Limited, MB Sugars & Pharmaceuticals Limited, CIL Laboratories Pvt Ltd, Sainor Pharma Pvt Ltd, Umang Pharmatech Pvt Ltd, Nami Lifesciences Pvt Ltd, Lograns Pharma Private Limited, Rainbow Health Care Products, Chemit Laboratories, Concord Drugs Limited, Nanjing Joyfulchem Co. Ltd., Praful International Corporation, Pellets Pharma Limited, Vision Pharmacoat Pvt Ltd, Spansules Pharma, and Ravoos Laboratories Ltd.

Significant Acquisition Enhances Capabilities in Packaging
In March 2023, Colorcon Inc., a US-based company known for pharmaceutical film coatings, acquired Airnov Healthcare Packaging, a France-based firm specializing in controlled atmosphere packaging. This strategic acquisition strengthened Colorcon's portfolio by incorporating solutions that protect pharmaceuticals against moisture and oxygen, thereby enhancing stability and shelf-life. Airnov's expertise in active materials, innovative plastic processing, and functional design adds valuable capabilities to Colorcon's offerings for the pharmaceutical industry.

Emerging Trends Focused on Particle Engineering and Safety
Leading pharmaceutical pellets companies are investing in advanced technologies to improve particle engineering, containment, and precision in drug formulation. Particle engineering platforms enable controlled manufacturing processes that produce pellets with specific size, shape, and potency, ensuring safety and compliance with regulations.

For example, in May 2024, Schedio SA, an engineering firm based in the US, introduced the High Potent Pilot Particle Engineering Platform. This sophisticated system supports up to 465 configurations and integrates with spray dryers and jet mills to optimize particle engineering for high-potency compounds. Its design emphasizes high containment and user-friendly controls to meet safety standards and regulatory requirements in pharmaceutical production.

Breakdown of Key Pharmaceutical Pellets Market Segments
The pharmaceutical pellets market is categorized into distinct segments for a detailed analysis:

1) By Technology:
- Extrusion
- Fluid Bed Granulation
- Dry Powder Layering
- Solution and Suspension Layering
- Spray Congealing
- Spray Drying

2) By Mechanism of Action:
- Diffusion
- Erosion
- Osmosis

3) By Technique:
- Direct
- Melt
- Wet
- Dry

4) By End-User:
- Pharmaceutical
- Nutraceutical

Further subsegments include:
- Extrusion divided into Melt Extrusion and Solvent-Based Extrusion
- Fluid Bed Granulation split into Top-Spray and Bottom-Spray Granulation
- Dry Powder Layering comprising Powder Layering on Inert Cores and Coating Techniques
- Solution and Suspension Layering divided into Solution Layering and Suspension Layering
- Spray Congealing includes Hot Melt Spraying and Cooling Methods
- Spray Drying categorized into Single-Stage and Multi-Stage Spray Drying

This comprehensive segmentation helps in understanding the market's complexity and the varied technological approaches used in pharmaceutical pellet production worldwide.

New strategic additions in our 2026 market reports include market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, along with updated graphics and tables.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pharmaceutical Pellets Market Report 2026 Market Outlook Supported By A Forecast 11.7% CAGR here

News-ID: 4673330 • Views: …

More Releases from The Business Research Company

Zymfentra Market Report Examines Leading Companies And Growth Opportunities
Zymfentra Market Report Examines Leading Companies And Growth Opportunities
Understanding the Future Outlook of the Zymfentra Market The Zymfentra market has been evolving steadily, driven by scientific advances and growing healthcare infrastructure. Looking ahead to 2030, the market is expected to witness considerable growth fueled by multiple factors influencing both development and patient care. Market Size and Growth Drivers for the Zymfentra Market During the historical period, growth was primarily propelled by improvements in recombinant enzyme technology and better diagnostic…
Zenpep Market Report Provides Insights Into Market Evolution And Growth Prospects
Zenpep Market Report Provides Insights Into Market Evolution And Growth Prospect …
The Zenpep market is gaining momentum as advancements in digestive health treatments and better disease management continue to evolve. With rising awareness and improved therapies, this sector is positioned for steady growth in the coming years. Let's explore the current market value, key factors driving expansion, leading players, and important segments shaping the future of Zenpep. Projected Market Value and Growth Drivers for Zenpep by 2030 Historical growth in the Zenpep…
Xyntha,Xyntha Solofuse Market Report Examines Leading Companies And Growth Opportunities
Xyntha,Xyntha Solofuse Market Report Examines Leading Companies And Growth Oppor …
The market for Xyntha and Xyntha Solofuse is poised for significant growth as advancements in hemophilia A treatment continue to evolve. With shifts toward more effective therapies and improved patient management strategies, this industry is set to witness substantial expansion in the coming years. Let's explore the current market value, the key factors driving growth, prominent players, and the main market segments shaping the landscape. Expected Market Value of the Xyntha…
Xembify Market Report Provides Insights Into Market Evolution And Growth Prospects
Xembify Market Report Provides Insights Into Market Evolution And Growth Prospec …
The Xembify market is gaining considerable attention due to advances in treatment options and increased awareness of immune-related disorders. This sector is evolving rapidly, driven by improvements in therapies and expanding patient access. Let's explore the current market size, key growth drivers, prominent players, and emerging trends shaping the future of Xembify. Market Growth and Prospects for the Xembify Market The historical expansion of the Xembify market is largely linked to…

All 5 Releases


More Releases for Pharma

Schizophrenia Market Forecast 2036: Rising Demand, Novel Therapies, and Commerci …
The Key Schizophrenia Companies in the market include - Teva Pharmaceutical Industries, Royalty Pharma, MedinCell, Sumitomo Pharma, Otsuka Pharmaceuticals, Reviva Pharmaceuticals, Minerva Neurosciences, Mitsubishi Tanabe Pharma, Lundbeck, Intra-cellular Therapies, Sumitomo Pharma, Otsuka Pharma, Reviva Pharmaceuticals, Minerva Neurosciences, Karuna Therapeutics, Acadia Pharmaceuticals, Boehringer Ingelheim, Otsuka Pharmaceutical, Lyndra Therapeutics, Neurocrine Biosciences, and others. (Albany, New York) - October 19, 2026: DelveInsight's report "Schizophrenia Market Insights, Epidemiology, and Market Forecast-2036" provides a comprehensive analysis…
Schizophrenia Market Gains Momentum with Expanding Pipeline and Investment Poten …
The Key Schizophrenia Companies in the market include - Teva Pharmaceutical Industries, Royalty Pharma, MedinCell, Sumitomo Pharma, Otsuka Pharmaceuticals, Reviva Pharmaceuticals, Minerva Neurosciences, Mitsubishi Tanabe Pharma, Lundbeck, Intra-cellular Therapies, Sumitomo Pharma, Otsuka Pharma, Acadia Pharmaceuticals, Boehringer Ingelheim, Cerevel Therapeutics, AstraZeneca, Eli Lilly and Company, Karuna Therapeutics, Neurocrine Biosciences, and others. DelveInsight's report "Schizophrenia Market Insights, Epidemiology, and Market Forecast-2036" provides a comprehensive analysis of the Schizophrenia landscape. The report delivers detailed…
Schizophrenia Market: Expanding Revenue Landscape to 2034 - DelveInsight | Teva …
The Key Schizophrenia Companies in the market inlclude - Teva Pharmaceutical Industries, Royalty Pharma, MedinCell, Sumitomo Pharma, Otsuka Pharmaceuticals, Reviva Pharmaceuticals, Minerva Neurosciences, Mitsubishi Tanabe Pharma, Lundbeck, Intra-cellular Therapies, Sumitomo Pharma, Otsuka Pharma, Reviva Pharmaceuticals, and others. DelveInsight's report "Schizophrenia Market Insights, Epidemiology, and Market Forecast-2034" provides a comprehensive analysis of the Schizophrenia landscape. The report delivers detailed insights into the disease, including historical and projected epidemiology, helping stakeholders understand the…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As…
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the…